UNIQA Insurance Group AG (0GDR)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 16.90 |
|---|---|
| 52-week range | 11.78 – 19.00 |
| Return, 1 month / 3 months | −8.0% / −1.5% |
| Return, 1 year / 3 years | +35.9% / +161.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 24.3% |
| Worst drawdown (1 year) | -13.5% |
| Average daily value traded | 0.46M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UNIQA Insurance Group is an Austrian insurance company based in Vienna. It provides life, health, property and casualty insurance to private individuals and corporate customers. The group serves customers across Austria and several countries in Central and Eastern Europe, offering both personal insurance cover and risk protection for businesses. Its services include savings and retirement products, health cover, and damage and liability insurance for homes, vehicles and commercial operations.
On this site UNIQA Insurance Group AG appears as a stock on the London Exchange (UK), code 0GDR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UNIQA Insurance Group AG (0GDR) trades on the London Exchange in UK. It last closed at EUR 16.90 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 790 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.9% and over the last three months it fell 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.5% | ||
| From 52-week high | -10.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.5% | ||
| 6-month return | 7.5% | ||
| 12-month return, skipping the last month | 47.7% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.5% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.46M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −8.0% |
| 3 months | −1.5% |
| 6 months | +7.5% |
| 1 year | +35.9% |
| 3 years | +161.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.93 / 16.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | EUR 0.7200 |
| 12 Jun 2025 | EUR 0.6000 |
| 13 Jun 2024 | EUR 0.5700 |
| 15 Jun 2023 | EUR 0.5500 |
| 1 Jun 2022 | EUR 0.5500 |
| 10 Jun 2021 | EUR 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.